Action CALTX CALLIDITAS THERAPEUTICS AB
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Calliditas Therapeutics AB

Actions

CALTX

SE0010441584

Marché Fermé - Nasdaq Stockholm
Autres places de cotation
 17:29:52 26/04/2024 		Varia. 5j. Varia. 1 janv.
103,7 SEK -0,38% Graphique intraday de Calliditas Therapeutics AB +3,18% -18,41%
25/04 Les actions européennes négociées aux États-Unis sous forme de certificats de dépôt américains sont en légère hausse jeudi matin MT
24/04 Calliditas Therapeutics déclare que l'étude OLE montre une réponse au traitement cohérente avec les résultats de l'étude NefIgArd de stade avancé MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading
Calliditas Therapeutics' 2023 Annual Report Published
Calliditas Therapeutics Says OLE Study Shows Treatment Response Consistent With Late-Stage NefIgArd Study's Findings
Calliditas Announces Positive NefIgArd Open Label Extension Results
Calliditas Therapeutics AB Announces Positive NefIgArd Open Label Extension Results
European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down
Calliditas Therapeutics Presents Additional Data Analyses from the Phase 3 NeflgArd trial of Nefecon in Primary IgA Nephropathy at the ISN World Congress of Nephrology 2024
Calliditas Therapeutics AB Presents Additional Data Analyses from the Phase 3 NeflgArd Trial of Nefecon in Primary IgA Nephropathy at the ISN World Congress of Nephrology 2024
Calliditas Therapeutics Presents Additional Data Analyses from the Phase 3 NeflgArd trial of Nefecon in Primary IgA Nephropathy at the ISN World Congress of Nephrology 2024
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading
Calliditas Therapeutics to Attend Conferences in April
Calliditas Therapeutics to Present Nefecon Data at the ISN World Congress of Nephrology April 13 - 16 in Buenos Aires
Calliditas Therapeutics AB to Present Nefecon Data At the ISN World Congress of Nephrology in Buenos Aires
Calliditas Therapeutics Gets US Patent Allowance for Cancer Treatment Inhibitor
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action CALTX
  4. Actualités Calliditas Therapeutics AB
  5. Autres langues